Price Target Changed • May 15
Price target increased by 7.6% to CA$12.38 Up from CA$11.50, the current price target is an average from 4 analysts. New target price is 6.3% above last closing price of CA$11.64. Stock is up 32% over the past year. The company posted earnings per share of CA$0.85 last year. Annonce • May 14
KP Tissue Inc. to Report Q1, 2026 Results on May 14, 2026 KP Tissue Inc. announced that they will report Q1, 2026 results on May 14, 2026 Annonce • Apr 07
KP Tissue Inc., Annual General Meeting, Jun 15, 2026 KP Tissue Inc., Annual General Meeting, Jun 15, 2026. Upcoming Dividend • Mar 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 March 2026. Payment date: 15 April 2026. Trailing yield: 6.5%. Within top quartile of Canadian dividend payers (5.7%). Higher than average of industry peers (3.0%). Declared Dividend • Feb 20
Fourth quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 6.7%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 106% to bring the payout ratio under control, which is more than the 36% EPS growth achieved over the last 5 years. Annonce • Feb 18
Kp Tissue Declares A Quarterly Dividend, Payable on April 15, 2026 KP Tissue Inc. has declared a quarterly dividend of $0.18 per common share, payable on April 15, 2026, to shareholders of record at the close of business on March 31, 2026, subject to applicable law. Annonce • Jan 19
KP Tissue Inc. to Report Q4, 2025 Results on Feb 18, 2026 KP Tissue Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 18, 2026 Upcoming Dividend • Dec 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 December 2025. Payment date: 15 January 2026. Trailing yield: 7.0%. Within top quartile of Canadian dividend payers (5.9%). Higher than average of industry peers (3.0%). Declared Dividend • Nov 16
Third quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 7.6%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to grow by 37% over the next year, which should provide support to the dividend and adequate earnings cover. Annonce • Nov 13
KP Tissue Inc. Declares A Quarterly Dividend, Payable on January 15, 2026 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on January 15, 2026, to shareholders of record at the close of business on December 31, 2025, subject to applicable law. Annonce • Oct 09
KP Tissue Inc. to Report Q3, 2025 Results on Nov 13, 2025 KP Tissue Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025 Upcoming Dividend • Sep 22
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 29 September 2025. Payment date: 15 October 2025. Trailing yield: 7.6%. Within top quartile of Canadian dividend payers (5.8%). Higher than average of industry peers (2.8%). New Risk • Sep 04
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 7x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m. Declared Dividend • Aug 15
Dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 7.5%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 80% to bring the payout ratio under control. EPS is expected to grow by 22% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio. Annonce • Aug 14
KP Tissue Inc. Declares Quarterly Dividend, Payable on October 15, 2025 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on October 15, 2025, to shareholders of record at the close of business on September 30, 2025, subject to applicable law. Annonce • Jul 14
KP Tissue Inc. to Report Q2, 2025 Results on Aug 13, 2025 KP Tissue Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 13, 2025 Upcoming Dividend • Jun 23
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 30 June 2025. Payment date: 15 July 2025. Trailing yield: 7.9%. Within top quartile of Canadian dividend payers (6.1%). Higher than average of industry peers (2.7%). Declared Dividend • May 18
First quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 8.2%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 162% to bring the payout ratio under control. EPS is expected to grow by 36% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio. Price Target Changed • May 15
Price target increased by 12% to CA$9.38 Up from CA$8.38, the current price target is an average from 4 analysts. New target price is 8.6% above last closing price of CA$8.63. Stock is up 4.1% over the past year. The company is forecast to post earnings per share of CA$0.59 for next year compared to CA$0.24 last year. Annonce • May 15
KP Tissue Inc. Declares Quarterly Dividend, Payable on July 15, 2025 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on July 15, 2025, to shareholders of record at the close of business on June 30, 2025, subject to applicable law. Annonce • Apr 14
KP Tissue Inc. to Report Q1, 2025 Results on May 14, 2025 KP Tissue Inc. announced that they will report Q1, 2025 results Pre-Market on May 14, 2025 Annonce • Apr 09
KP Tissue Inc., Annual General Meeting, Jun 23, 2025 KP Tissue Inc., Annual General Meeting, Jun 23, 2025. Upcoming Dividend • Mar 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 March 2025. Payment date: 15 April 2025. Trailing yield: 9.0%. Within top quartile of Canadian dividend payers (6.3%). Higher than average of industry peers (2.5%). Declared Dividend • Mar 07
Fourth quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 8.9%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 25% to bring the payout ratio under control. EPS is expected to grow by 98% over the next 2 years, which is sufficient to bring the dividend into a sustainable range. New Risk • Mar 06
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (CA$147k sold). Market cap is less than US$100m (CA$80.3m market cap, or US$56.2m). Annonce • Mar 06
KP Tissue Inc. Declares Quarterly Dividend, Payable on April 15, 2025 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025, subject to applicable law. Annonce • Jan 22
KP Tissue Inc. to Report Q4, 2024 Results on Mar 05, 2025 KP Tissue Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 05, 2025 Upcoming Dividend • Dec 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 December 2024. Payment date: 15 January 2025. Trailing yield: 8.8%. Within top quartile of Canadian dividend payers (6.4%). Higher than average of industry peers (2.6%). Recent Insider Transactions • Dec 15
Insider recently sold CA$147k worth of stock On the 10th of December, Mario Gosselin sold around 18k shares on-market at roughly CA$8.19 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of CA$99k more than they bought in the last 12 months. Declared Dividend • Nov 15
Third quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 8.7%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 25% to bring the payout ratio under control. EPS is expected to grow by 11% over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Annonce • Nov 13
KP Tissue Inc. Declares Quarterly Dividend, Payable on January 15, 2025 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024, subject to applicable law. Annonce • Oct 15
KP Tissue Inc. to Report Q3, 2024 Results on Nov 13, 2024 KP Tissue Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 13, 2024 Upcoming Dividend • Sep 20
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 15 October 2024. Trailing yield: 8.5%. Within top quartile of Canadian dividend payers (5.8%). Higher than average of industry peers (2.4%). Declared Dividend • Aug 15
Dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 8.5%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to grow by 4.6% over the next year, which should provide support to the dividend and adequate earnings cover. Annonce • Aug 14
KP Tissue Inc. Declares Quarterly Dividend, Payable on October 15, 2024 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024, subject to applicable law. Annonce • Jul 16
KP Tissue Inc. to Report Q2, 2024 Results on Aug 13, 2024 KP Tissue Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 13, 2024 Price Target Changed • May 15
Price target decreased by 9.9% to CA$9.13 Down from CA$10.13, the current price target is an average from 4 analysts. New target price is 10% above last closing price of CA$8.26. Stock is down 20% over the past year. The company is forecast to post earnings per share of CA$0.55 next year compared to a net loss per share of CA$0.50 last year. Annonce • May 15
KP Tissue Inc. Declares a Quarterly Dividend, Payable on July 15, 2024 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024, subject to applicable law. New Risk • Apr 16
New major risk - Revenue and earnings growth Earnings have declined by 42% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (CA$84.3m market cap, or US$61.0m). Annonce • Apr 16
KP Tissue Inc. to Report Q1, 2024 Results on May 14, 2024 KP Tissue Inc. announced that they will report Q1, 2024 results Pre-Market on May 14, 2024 Annonce • Mar 30
KP Tissue Inc., Annual General Meeting, Jun 11, 2024 KP Tissue Inc., Annual General Meeting, Jun 11, 2024. Upcoming Dividend • Mar 21
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 15 April 2024. Trailing yield: 8.0%. Within top quartile of Canadian dividend payers (6.4%). Higher than average of industry peers (2.4%). Declared Dividend • Mar 10
Fourth quarter dividend of CA$0.18 announced Dividend of CA$0.18 is the same as last year. Ex-date: 28th March 2024 Payment date: 15th April 2024 Dividend yield will be 8.5%, which is higher than the industry average of 2.5%. Sustainability & Growth The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Price Target Changed • Mar 08
Price target decreased by 7.2% to CA$9.63 Down from CA$10.38, the current price target is an average from 4 analysts. New target price is 13% above last closing price of CA$8.50. Stock is down 18% over the past year. The company is forecast to post earnings per share of CA$0.66 next year compared to a net loss per share of CA$0.50 last year. Annonce • Mar 07
Kp Tissue Inc. Declares Quarterly Dividend on Common Share, Payable on April 15, 2024 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on April 15, 2024, to shareholders of record at the close of business on April 1, 2024, subject to applicable law. Annonce • Feb 08
KP Tissue Inc. to Report Q4, 2023 Results on Mar 07, 2024 KP Tissue Inc. announced that they will report Q4, 2023 results Pre-Market on Mar 07, 2024 Price Target Changed • Jan 12
Price target decreased by 7.4% to CA$10.38 Down from CA$11.20, the current price target is an average from 4 analysts. New target price is 16% above last closing price of CA$8.95. Stock is down 12% over the past year. The company is forecast to post a net loss per share of CA$0.09 next year compared to a net loss per share of CA$1.03 last year. Upcoming Dividend • Dec 22
Upcoming dividend of CA$0.18 per share at 8.0% yield Eligible shareholders must have bought the stock before 29 December 2023. Payment date: 15 January 2024. Trailing yield: 8.0%. Within top quartile of Canadian dividend payers (6.5%). Higher than average of industry peers (2.7%). Annonce • Dec 16
KP Tissue Inc Announces Executive Changes KP Tissue Inc. announced that Mr. Mark Holbrook has decided to retire from his position as Chief Financial Officer of KPT. Mr. Michael Keays will succeed him as of March 11, 2024. Mark Holbrook began his career 25 years ago with Scott Paper and continued to progress to more senior positions within Kruger Products. He was appointed CFO in 2012. Mr. Holbrook’s time with Kruger Products has been filled with numerous accomplishments, contributions, leadership and tremendous organizational impact. Over the course of his career, Mr. Holbrook has overseen all aspects of its financial operations, providing strategic insights to guide decision-making while ensuring the financial health of the company. He is an incredibly valued colleague with great institutional knowledge of Kruger Products and its industry. Keays holds a Bachelor of Commerce from the University of Ottawa and is a Chartered Professional Accountant. Annonce • Nov 09
KP Tissue Inc. Declares Quarterly Dividend, Payable on January 15, 2024 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on January 15, 2024 to shareholders of record at the close of business on January 2, 2024, subject to applicable law. Annonce • Oct 10
KP Tissue Inc. to Report Q3, 2023 Results on Nov 08, 2023 KP Tissue Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 08, 2023 Upcoming Dividend • Sep 21
Upcoming dividend of CA$0.18 per share at 7.1% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 16 October 2023. Trailing yield: 7.1%. Within top quartile of Canadian dividend payers (6.3%). Higher than average of industry peers (2.4%). New Risk • Sep 20
New major risk - Revenue and earnings growth Earnings have declined by 33% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (CA$102.2m market cap, or US$75.8m). Annonce • Aug 11
KP Tissue Inc. Declares Quarterly Dividend, Payable on October 16, 2023 KP Tissue Inc. declared a quarterly dividend of $0.18 per share to be paid on October 16, 2023 to shareholders of record at the close of business on October 2, 2023. New Risk • Jul 19
New major risk - Revenue and earnings growth Earnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Paying a dividend despite being loss-making. Market cap is less than US$100m (CA$103.3m market cap, or US$78.5m). Annonce • Jul 12
KP Tissue Inc. to Report Q2, 2023 Results on Aug 10, 2023 KP Tissue Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 10, 2023 Upcoming Dividend • Jun 22
Upcoming dividend of CA$0.18 per share at 6.9% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 17 July 2023. Trailing yield: 6.9%. Within top quartile of Canadian dividend payers (6.3%). Higher than average of industry peers (2.4%). Annonce • May 12
KP Tissue Inc. Declares A Quarterly Dividend Payable on July 17, 2023 The Board of Directors of KP Tissue Inc. declared a quarterly dividend of $0.18 per share to be paid on July 17, 2023 to shareholders of record at the close of business on June 30, 2023. Upcoming Dividend • Mar 23
Upcoming dividend of CA$0.18 per share at 7.1% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 17 April 2023. Trailing yield: 7.1%. Within top quartile of Canadian dividend payers (6.0%). Higher than average of industry peers (2.5%). Annonce • Feb 10
KP Tissue Inc. to Report Q4, 2022 Results on Mar 09, 2023 KP Tissue Inc. announced that they will report Q4, 2022 results at 9:30 AM, US Eastern Standard Time on Mar 09, 2023 Annonce • Nov 15
KP Tissue Inc. Announces Kruger Products to Shut Down Older Production Assets in Memphis KP Tissue Inc. and Kruger Products announced that it will shut down certain older and inefficient production assets including a Light Dry Crepe paper machine and six converting lines in early January, 2023 in Memphis, Tennessee. High quality facial tissue and premium Through Air Dry products will continue to be produced at its Memphis plant by approximately 400 remaining employees. The 165 employees impacted by this decision will receive severance and employment transition support. The Memphis plant is operated by Kruger Products' subsidiary, K.T.G. (USA) Inc. and after the asset shutdown will have a production capacity of 85,000 Metric Tonnes. The shutdown of these older assets will improve operating efficiencies and have a positive impact on the profitability of Memphis operations. Kruger Products will also be working closely with customers to make this a seamless transition. Annonce • Nov 10
KP Tissue Inc. Declares A Quarterly Dividend, payable on January 16, 2023 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on January 16, 2023 to shareholders of record at the close of business on December 31, 2022, subject to applicable law. Annonce • Oct 12
KP Tissue Inc. to Report Q3, 2022 Results on Nov 09, 2022 KP Tissue Inc. announced that they will report Q3, 2022 results Pre-Market on Nov 09, 2022 Upcoming Dividend • Sep 22
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 17 October 2022. Trailing yield: 6.5%. Within top quartile of Canadian dividend payers (5.7%). Higher than average of industry peers (2.6%). Annonce • Aug 13
KP Tissue Inc. Provides Earnings Guidance for Third Quarter of 2022 KP Tissue Inc. provided earnings guidance for third quarter of 2022. For the quarter, The company anticipates continued revenue momentum in the third quarter for both company's consumer and away-from-home segments and expect selling price increases across the business to begin offsetting inflation. Annonce • Aug 12
KP Tissue Inc. Declares A Quarterly Dividend, Payable on October 17, 2022 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on October 17, 2022 to shareholders of record at the close of business on October 3, 2022, subject to applicable law. Annonce • Jul 13
KP Tissue Inc. to Report Q2, 2022 Results on Aug 11, 2022 KP Tissue Inc. announced that they will report Q2, 2022 results at 9:30 AM, US Eastern Standard Time on Aug 11, 2022 Upcoming Dividend • Jun 22
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 15 July 2022. Trailing yield: 6.8%. Within top quartile of Canadian dividend payers (5.2%). Higher than average of industry peers (2.5%). Annonce • May 13
KP Tissue Declares A Quarterly Dividend, Payable on July 15, 2022 KP Tissue Inc. announced that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on July 15, 2022 to shareholders of record at the close of business on June 30, 2022, subject to applicable law. Annonce • Apr 16
KP Tissue Inc., Annual General Meeting, Jun 21, 2022 KP Tissue Inc., Annual General Meeting, Jun 21, 2022. Annonce • Apr 13
KP Tissue Inc. to Report Q1, 2022 Results on May 12, 2022 KP Tissue Inc. announced that they will report Q1, 2022 results Pre-Market on May 12, 2022 Upcoming Dividend • Mar 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of Canadian dividend payers (4.7%). Higher than average of industry peers (2.3%). Annonce • Feb 11
KP Tissue Inc. to Report Q4, 2021 Results on Mar 10, 2022 KP Tissue Inc. announced that they will report Q4, 2021 results Pre-Market on Mar 10, 2022 Upcoming Dividend • Dec 23
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 30 December 2021. Payment date: 17 January 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 6.9%. Within top quartile of Canadian dividend payers (4.7%). Higher than average of industry peers (2.2%). Upcoming Dividend • Sep 21
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 28 September 2021. Payment date: 15 October 2021. Trailing yield: 6.9%. Within top quartile of Canadian dividend payers (4.5%). Higher than average of industry peers (2.4%). Breakeven Date Change • Sep 14
Forecast to breakeven in 2021 The 6 analysts covering KP Tissue expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CA$29.7m in 2021. Earnings growth of 134% is required to achieve expected profit on schedule. Upcoming Dividend • Jun 22
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 15 July 2021. Trailing yield: 6.9%. Within top quartile of Canadian dividend payers (4.5%). Higher than average of industry peers (2.5%). Annonce • May 08
KP Tissue Inc. Declares a Quarterly Dividend, Payable on July 15, 2021 KP Tissue Inc. announced that the board of directors has declared a quarterly dividend of $0.18 per common share, payable on July 15, 2021 to shareholders of record at the close of business on June 30, 2021, subject to applicable law. Upcoming Dividend • Mar 24
Upcoming dividend of CA$0.18 per share Eligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 6.5%. Within top quartile of Canadian dividend payers (4.9%). Higher than average of industry peers (2.4%). Annonce • Mar 12
KP Tissue Inc. Declares Quarterly Dividend, Payable on April 15, 2021 The Board of Directors of KP Tissue Inc. declared a quarterly dividend of $0.18 per share to be paid on April 15, 2021 to shareholders of record at the close of business on April 1, 2021. Annonce • Mar 06
KP Tissue Inc. to Report Q4, 2020 Results on Mar 11, 2021 KP Tissue Inc. announced that they will report Q4, 2020 results Pre-Market on Mar 11, 2021 Is New 90 Day High Low • Feb 18
New 90-day low: CA$10.29 The company is down 13% from its price of CA$11.88 on 19 November 2020. The Canadian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$276 per share. Is New 90 Day High Low • Jan 29
New 90-day low: CA$10.49 The company is down 10.0% from its price of CA$11.64 on 30 October 2020. The Canadian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$276 per share. Is New 90 Day High Low • Dec 25
New 90-day low: CA$10.96 The company is down 19% from its price of CA$13.55 on 25 September 2020. The Canadian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$2,705 per share. Is New 90 Day High Low • Dec 05
New 90-day low: CA$11.54 The company is down 2.0% from its price of CA$11.81 on 04 September 2020. The Canadian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$2,389 per share. Is New 90 Day High Low • Oct 29
New 90-day low: CA$11.56 The company is down 1.0% from its price of CA$11.68 on 31 July 2020. The Canadian market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Household Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$215 per share. Annonce • Oct 07
KP Tissue Inc. to Report Q3, 2020 Results on Nov 05, 2020 KP Tissue Inc. announced that they will report Q3, 2020 results on Nov 05, 2020 Upcoming Dividend • Sep 22
Upcoming Dividend of CA$0.18 Per Share Will be paid on the 15th of October to those who are registered shareholders by the 29th of September. The trailing yield of 5.5% is below the top quartile of Canadian dividend payers (5.7%), but it is higher than industry peers (2.2%). Is New 90 Day High Low • Sep 18
New 90-day high: CA$12.67 The company is up 19% from its price of CA$10.69 on 19 June 2020. The Canadian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Household Products industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$109 per share. 
